newsfilter
← Latest News
Business Wire·

ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements

ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ:IPA), an AI-driven biotherapeutics company, announced today that the Company received written notification (the "Notification Letter") from the